Term Stimulation (Term Stim™) is an approach to ovarian stimulation that extends the follicular phase to the duration seen in the most fertile group of females. This is achieved by maintaining the level of FSH in blood within the narrow band optimized for the specific patient and by managing the inflammation within the follicle. We were able to demonstrate that it improves egg quality in younger as well as in patients of advanced reproductive age.
Term Stim™ (a short for Term Stimulation) came to existence as a derivative of a “sea changes in reproductive physiology” pioneered by Dr. Dmitri Dozortsev, Dr. Michael P. Diamond and Dr. Antonio Pellicer
Term Stim™ is not a mere extension of the duration of stimulation, but is based on a complex algorithm that maintains the level of FSH within a narrow band.
Term Stim helps those women who previously failed IVF multiple times due to poor egg quality, including those who are older. Term Stim™ requires more attention to detail and is more time-consuming than conventional ovarian stimulation. Therefore, at this time it has largely been used for patients who had two prior cycles of IVF with poor embryo quality, attributed to poor egg quality. Learn more
The patient is 42 years old with two prior failures due to poor egg quality. All attempts by the same physician in the same clinic and laboratory. Learn more
The patient is 37 years old with two prior failures due to low egg quality. All attempts by the same physician in the same clinic and laboratory. Learn more
Term Stim™ provides more data points to help physicians have a deeper insight into what is happening.
Convention stimulation relies on the level of E2 and follicle size to determine whether the response is adequate. Term Stim monitors the level of FSH to ensure that it remains within the safe range to achieve the desirable duration of artificial follicular phase (time).
Term Stim™ and Term IVF™ and pending patents are the property of Repronova LLC
Copyright © 2024 All rights reserved.